Marrone Bio Innovations Launches New CG Brand of Highly Effective Biological Solutions for Crop Protection in Cannabis and Ho...
June 04 2018 - 8:31AM
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a leading
provider of bio-based pest management and plant health products for
the agriculture, turf and ornamental and water treatment markets,
is pleased to announce the launch of REGALIA CG, GRANDEVO CG and
VENERATE CG, a portfolio of products designed to control highly
destructive pests and diseases, including powdery mildew, mites,
thrips and aphids, during Cannabis production and home gardening.
REGALIA CG, GRANDEVO CG and VENERATE CG are multi-state-approved
and extremely effective biological crop protection solutions for
clean green cultivation, with the ability to generate increased
yield and improved quality by reducing stresses from plant disease
and insect and mite pests to the plant. When incorporated into an
Integrated Pest Management (IPM) program, these products can serve
as the fundamental difference for successful growers.
"GRANDEVO and VENERATE are a game changer when it comes to IPM
programs,” said Kyle Stamback, Director of Cultivation
at NorthWestGrown i502 and owner of Lean
Cultivation LLC. “I have eliminated all other preventive
sprays and only use Grandevo and Venerate. These products have kept
my gardens clean and my beneficial bugs happy. I’ve seen great
results against all types of malice bugs, from leaf eaters to root
aphids."
“REGALIA has been considered the go-to product for powdery
mildew control in the Cannabis industry,” said Kyle. “When using
Regalia on a consistent schedule, I have documented increased vigor
and stalk size. Due to the overall plant health, my yields have
been remarkable. As a result of tank mixing Regalia and other great
products offered by MBI, my plants have never been healthier and my
IPM has never been simpler.”
REGALIA CG, GRANDEVO CG and VENERATE CG also help grow
operations care for their employees and the environment. They are
harvest flexible and worker-friendly with a four-hour re-entry
interval, minimal personal protective equipment requirements and
the ability to be used right before harvest without concern for
synthetic chemical residues.
“Outreach to hundreds of growers and industry leaders helped MBI
create a solution that addresses needs in information sharing,
education and training, ultimately producing products they can use
with confidence backed by science,” said Lisa Malabad, Cannabis
Segment Lead at Marrone Bio Innovations. “We continue to work with
state regulatory agencies to ensure each of our products is aligned
with all requirements and guidelines, giving growers peace of
mind.”
REGALIA CG and VENERATE CG are available in one quart and
one-gallon sizes. Grandevo CG is available in one and four-pound
packages.
About Marrone Bio Innovations
Bio With Bite. Marrone Bio
Innovations, Inc. (NASDAQ:MBII) strives to lead the movement to a
more sustainable world through the discovery, development and
promotion of biological products for crop protection and plant
health. MBI’s effective and environmentally responsible pest
management solutions help customers operate more sustainably while
uniquely improving plant health and increasing crop yields. MBI’s
currently available commercial products are Regalia®, Grandevo®,
Venerate®, Majestene®, Haven® StargusTM and AmplitudeTM, Zelto® and
Zequanox®.
Marrone Bio Innovations is dedicated to pioneering smart
biopesticide solutions that support a better tomorrow for both
farmers, turf managers and consumers around the globe. For more
information, please visit www.marronebio.com.
Marrone Bio Innovations Forward Looking
StatementsThis press release contains forward-looking
statements that involve substantial risks and uncertainties.
All statements, other than statements of historical facts, included
in this press release regarding strategy, future operations and
plans, including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing MBI’s views as of any subsequent date. Examples
of such statements include statements regarding the potential of
Regalia, Grandevo and Venerate CG and other MBI products in the US
and Canada, market projections, including the potential benefits of
Regalia CG. Such forward-looking statements are based on
information available to the Company as of the date of this release
and involve a number of risks and uncertainties, some beyond the
Company's control, that could cause actual results to differ
materially from those anticipated by these forward-looking
statements, including consumer, regulatory and other factors
affecting demand for the MBI’s products, any difficulty in
marketing MBI’s products in its target markets, competition in the
market for pest management products, lack of understanding of
bio-based pest management products by customers and growers.
Additional information that could lead to material changes in MBI’s
performance is contained in its filings with the SEC. MBI is
under no obligation to, and expressly disclaims any responsibility
to, update or alter forward-looking statements contained in this
release, whether as a result of current information, future events
or otherwise.
Marrone Bio Innovations Contacts: Kevin
Hammill, Chief Commercial OfficerKeith Pitts, Sr. VP of Regulatory
and Government Affairs and Chief Sustainability Officer Lisa
Malabad, Product Marketing Manager and Cannabis Segment Lead
Telephone: +1 (530) 750-2800 Email: Info@marronebio.com
MBI Investor Relations: Greg Falesnik Managing
Director MZ Group – MZ North America Main: 949-385-6449
MBII@mzgroup.us www.mzgroup.us
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Mar 2024 to Apr 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Apr 2023 to Apr 2024